Compare NATR & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NATR | SOPH |
|---|---|---|
| Founded | 1972 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.0M | 367.7M |
| IPO Year | 1995 | 2021 |
| Metric | NATR | SOPH |
|---|---|---|
| Price | $23.64 | $4.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $28.33 | $7.00 |
| AVG Volume (30 Days) | ★ 123.8K | 101.2K |
| Earning Date | 03-10-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | N/A |
| EPS | ★ 1.06 | N/A |
| Revenue | ★ $480,144,000.00 | N/A |
| Revenue This Year | $7.76 | $23.09 |
| Revenue Next Year | $3.82 | $19.57 |
| P/E Ratio | $22.42 | ★ N/A |
| Revenue Growth | ★ 5.67 | N/A |
| 52 Week Low | $11.01 | $2.58 |
| 52 Week High | $28.14 | $5.70 |
| Indicator | NATR | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 40.10 | 50.05 |
| Support Level | $23.14 | $4.54 |
| Resistance Level | $24.12 | $4.86 |
| Average True Range (ATR) | 1.37 | 0.27 |
| MACD | -0.17 | 0.03 |
| Stochastic Oscillator | 17.41 | 43.75 |
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.